192 related articles for article (PubMed ID: 26577686)
1. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma.
Fernández-Aceñero MJ; Cortés D; Gómez del Pulgar T; Cebrián A; Estrada L; Martínez-Useros J; Celdrán A; García-Foncillas J; Pastor C
Pathol Oncol Res; 2016 Apr; 22(2):377-83. PubMed ID: 26577686
[TBL] [Abstract][Full Text] [Related]
2. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
3. Polo-like kinase 1 is overexpressed in renal cancer and participates in the proliferation and invasion of renal cancer cells.
Zhang G; Zhang Z; Liu Z
Tumour Biol; 2013 Jun; 34(3):1887-94. PubMed ID: 23494182
[TBL] [Abstract][Full Text] [Related]
4. Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy.
Cebrián A; Gómez Del Pulgar T; Fernández-Aceñero MJ; Borrero-Palacios A; Del Puerto-Nevado L; Martínez-Useros J; Marín-Arango JP; Caramés C; Vega-Bravo R; Rodríguez-Remírez M; Manzarbeitia F; García-Foncillas J
Pathol Res Pract; 2016 Dec; 212(12):1133-1137. PubMed ID: 27712975
[TBL] [Abstract][Full Text] [Related]
5. High expression of polo-like kinase 1 is associated with the metastasis and recurrence in urothelial carcinoma of bladder.
Zhang Z; Zhang G; Kong C
Urol Oncol; 2013 Oct; 31(7):1222-30. PubMed ID: 22192978
[TBL] [Abstract][Full Text] [Related]
6. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
7. Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.
Goi T; Kurebayashi H; Ueda Y; Naruse T; Nakazawa T; Koneri K; Hirono Y; Katayama K; Yamaguchi A
Oncotarget; 2015 Oct; 6(31):31758-66. PubMed ID: 26372733
[TBL] [Abstract][Full Text] [Related]
8. Polo-like kinase 1 is overexpressed in colorectal cancer and participates in the migration and invasion of colorectal cancer cells.
Han DP; Zhu QL; Cui JT; Wang PX; Qu S; Cao QF; Zong YP; Feng B; Zheng MH; Lu AG
Med Sci Monit; 2012 Jun; 18(6):BR237-46. PubMed ID: 22648245
[TBL] [Abstract][Full Text] [Related]
9. CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.
Stremitzer S; Stift J; Graf A; Singh J; Starlinger P; Gruenberger B; Tamandl D; Gruenberger T
Ann Surg Oncol; 2015 Apr; 22(4):1315-23. PubMed ID: 25323471
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters.
Singh L; Pushker N; Sen S; Singh MK; Chauhan FA; Kashyap S
Clin Exp Ophthalmol; 2015 Aug; 43(6):550-7. PubMed ID: 25754767
[TBL] [Abstract][Full Text] [Related]
11. FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer.
Kawase M; Toyama T; Takahashi S; Sato S; Yoshimoto N; Endo Y; Asano T; Kobayashi S; Fujii Y; Yamashita H
Breast Cancer; 2015 May; 22(3):308-16. PubMed ID: 23771556
[TBL] [Abstract][Full Text] [Related]
12. Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers.
Takahashi T; Sano B; Nagata T; Kato H; Sugiyama Y; Kunieda K; Kimura M; Okano Y; Saji S
Cancer Sci; 2003 Feb; 94(2):148-52. PubMed ID: 12708489
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns of polo-like kinase 1 in human gastric cancer.
Weichert W; Ullrich A; Schmidt M; Gekeler V; Noske A; Niesporek S; Buckendahl AC; Dietel M; Denkert C
Cancer Sci; 2006 Apr; 97(4):271-6. PubMed ID: 16630118
[TBL] [Abstract][Full Text] [Related]
14. Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer.
Tut TG; Lim SH; Dissanayake IU; Descallar J; Chua W; Ng W; de Souza P; Shin JS; Lee CS
PLoS One; 2015; 10(6):e0129313. PubMed ID: 26047016
[TBL] [Abstract][Full Text] [Related]
15. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
[TBL] [Abstract][Full Text] [Related]
16. Prokineticin 1 protein expression is a useful new prognostic factor for human sporadic colorectal cancer.
Nakazawa T; Goi T; Hirono Y; Yamaguchi A
Ann Surg Oncol; 2015 May; 22(5):1496-503. PubMed ID: 25331005
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma.
Wang XQ; Zhu YQ; Lui KS; Cai Q; Lu P; Poon RT
Clin Cancer Res; 2008 Nov; 14(21):6813-20. PubMed ID: 18980975
[TBL] [Abstract][Full Text] [Related]
18. High pKDR immunohistochemical expression is an unfavourable prognostic biomarker in patients with advanced colorectal cancer treated with chemotherapy plus bevacizumab.
Garde-Noguera J; Gil-Raga M; Evgenyeva E; García JA; Llombart-Cussac A; Camps-Herrero C
Clin Transl Oncol; 2016 Apr; 18(4):405-12. PubMed ID: 26307753
[TBL] [Abstract][Full Text] [Related]
19. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications.
Weichert W; Kristiansen G; Winzer KJ; Schmidt M; Gekeler V; Noske A; Müller BM; Niesporek S; Dietel M; Denkert C
Virchows Arch; 2005 Apr; 446(4):442-50. PubMed ID: 15785925
[TBL] [Abstract][Full Text] [Related]
20. [Influence of silencing Polo-like kinase 1 on migration and invasion of colorectal cancer cells].
Han DP; Cui JT; Lu AG; Chen XH; Feng B; Zong YP; Qu S; Cao QF; Zheng MH
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):61-4. PubMed ID: 21271384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]